Literature DB >> 1710175

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.

A J Verkerk1, M Pieretti, J S Sutcliffe, Y H Fu, D P Kuhl, A Pizzuti, O Reiner, S Richards, M F Victoria, F P Zhang.   

Abstract

Fragile X syndrome is the most frequent form of inherited mental retardation and is associated with a fragile site at Xq27.3. We identified human YAC clones that span fragile X site-induced translocation breakpoints coincident with the fragile X site. A gene (FMR-1) was identified within a four cosmid contig of YAC DNA that expresses a 4.8 kb message in human brain. Within a 7.4 kb EcoRI genomic fragment, containing FMR-1 exonic sequences distal to a CpG island previously shown to be hypermethylated in fragile X patients, is a fragile X site-induced breakpoint cluster region that exhibits length variation in fragile X chromosomes. This fragment contains a lengthy CGG repeat that is 250 bp distal of the CpG island and maps within a FMR-1 exon. Localization of the brain-expressed FMR-1 gene to this EcoRI fragment suggests the involvement of this gene in the phenotypic expression of the fragile X syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710175     DOI: 10.1016/0092-8674(91)90397-h

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  1085 in total

1.  FMR1 CGG-repeat instability in single sperm and lymphocytes of fragile-X premutation males.

Authors:  S L Nolin; G E Houck; A D Gargano; H Blumstein; C S Dobkin; W T Brown
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  Survey of the fragile X syndrome CGG repeat and the short-tandem-repeat and single-nucleotide-polymorphism haplotypes in an African American population.

Authors:  D C Crawford; C E Schwartz; K L Meadows; J L Newman; L F Taft; C Gunter; W T Brown; N J Carpenter; P N Howard-Peebles; K G Monaghan; S L Nolin; A L Reiss; G L Feldman; E M Rohlfs; S T Warren; S L Sherman
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

3.  Analysis of replication timing at the FRA10B and FRA16B fragile site loci.

Authors:  O Handt; E Baker; S Dayan; S M Gartler; E Woollatt; R I Richards; R S Hansen
Journal:  Chromosome Res       Date:  2000       Impact factor: 5.239

4.  Repeat polymorphisms within gene regions: phenotypic and evolutionary implications.

Authors:  J D Wren; E Forgacs; J W Fondon; A Pertsemlidis; S Y Cheng; T Gallardo; R S Williams; R V Shohet; J D Minna; H R Garner
Journal:  Am J Hum Genet       Date:  2000-07-07       Impact factor: 11.025

Review 5.  Genetic effects on human cognition: lessons from the study of mental retardation syndromes.

Authors:  P Nokelainen; J Flint
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

6.  Duty to re-contact: a study of families at risk for Fragile X.

Authors:  Lynn E Bernard; Barbara McGillivray; Margot I Van Allen; J M Friedman; Sylvie Langlois
Journal:  J Genet Couns       Date:  1999-02       Impact factor: 2.537

7.  FMR1 haplotype analyses among Indians: a weak founder effect and other findings.

Authors:  Deepti Sharma; Meena Gupta; B K Thelma
Journal:  Hum Genet       Date:  2002-12-14       Impact factor: 4.132

8.  A Screening Tool to Measure Eye Contact Avoidance in Boys with Fragile X Syndrome.

Authors:  Scott S Hall; Kaitlin M Venema
Journal:  J Autism Dev Disord       Date:  2017-07

9.  Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome.

Authors:  Bradford Coffee; Fuping Zhang; Stephanie Ceman; Stephen T Warren; Daniel Reines
Journal:  Am J Hum Genet       Date:  2002-09-13       Impact factor: 11.025

10.  Covariate adjusted correlation analysis with application to FMR1 premutation female carrier data.

Authors:  Damla Sentürk; Danh V Nguyen; Flora Tassone; Randi J Hagerman; Raymond J Carroll; Paul J Hagerman
Journal:  Biometrics       Date:  2009-01-23       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.